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Impact of heart rate control on prognosis in patients with ST-segment elevation
myocardial infarction
Wang Zhihao1, Liu Dayi2
1Departments of Geriatrics Medicine, The Bethune First Hospital of Jilin University,
Changchun 130021, China, 2Department of Cardiology, General Hospital of Daqing
Oil Field, Heilongjing Daqing 163001, China
Objectives: To investigate the impact of the heart rate control on Cardiovascular
events and cardiac function in patients with ST-segment elevation myocardial
infarction (STEMI).
Methods: It was a retrospective analysis of 228 patients with ST-segment elevation
myocardial infarction treated in the department of Cardiology of the 1st Hospital of
Jilin University enrolled in this study from March, 2013 through March, 2014. The
patients were randomly divided into 2 groups of enhanced heart rate control group A
(112 cases) and control group B (116 cases).Group A: with Metoprolol Succinate
Sustained-release Tablets. Target resting heart rate was 55-65 beats / min. The starting
dose of Metoprolol Succinate Sustained-release Tablets was 47.5 mg, and we cali-
brated resting heart rate once a week, if the heart rate was greater than 65 beats / min,
the Metoprolol Succinate Sustained-release Tablets increase the amount of 23.75mg
until the resting heart rate reached the standard. Random sample of the same period of
hospitalization ST segment elevation myocardial infarction as a control group with no
Metoprolol Succinate Sustained-release Tablets. We recorded series of events within
one year including of episodes of angina, recurrent myocardial infarction, coronary
revascularization, heart failure, left ventricular end-diastolic diameter, serum brain
natriuretic peptide (BNP), left ventricular ejection fraction (LVEF), fatal arrhythmias
and cardiac deaths.
Results: Enhanced heart rate control group was signiﬁcantly lower in angina pectoris,
coronary revascularization, heart failure, cardiac death, re-infarction, fatal arrhyth-
mias, Left ventricular end-diastolic diameter and BNP than control group (P<0.05).
LVEF was signiﬁcantly higher in enhanced heart rate control group than in control
group (P<0.05).
Conclusions: The study shows that heart rate control with Metoprolol Succinate
Sustained-release Tablets can antagonize sympathetic activity as well and may
improve prognosis in patients with STEMI.
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Clinical epidemiological study of the hypothesis of endogenous collateral wind on
Acute coronary syndrome
Wang Xian1,2, Yang Ran1,2, Sun Tian1,2, Li Hong-Mei1,2, Chen Jian-Xin2
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Objectives: To study the distribution characteristics of TCM four diagnostic infor-
mation and syndrome of patients with Acute Coronary Syndrome (ACS).
Methods: The demographic data and TCM four diagnostic information of 300 eligible
patients were collected through the clinical epidemiologic methods, and then hier-
achical clustering methods and frequency analysis methods were adopted for data
analyzing by STATISTICA 6 software and SPSS17.0 statistical software.
Results: (1) Endogenous collateral wind was an independent syndrome of TCM chest
pain; (2) Qi deﬁciency was the main and facultative syndrome of endogenous
collateral wind; (3) Blood stasis syndrome had less correlation with endogenous
collateral wind than Qi deﬁciency; (4) Endogenous collateral wind syndrome also
related to Yin deﬁciency.
Conclusions: It is the preliminary evidence that endogenous collateral wind is the
important pathogenesis of acute coronary syndrome.
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Outcomes in Patients with Non-ST-Elevation Acute Coronary Syndrome
Randomly Assigned to An Invasive as Compared with A Conservative Strategy:
A Meta-Analysis
Li Yingqing1, Liu Na2, Lu Jianhua1
1Guangzhou First People’s Hospital, Guangzhou Medical University, 2Sun Yat-sen
University Cancer Center
Objectives: The goal of the present study was to compare the prognosis of patients
with non-ST-elevation acute coronary syndromes (NSTE-ACS) which treated by
invasive or conservative treatment strategy.
Methods: We performed a meta-analysis of studies in patients with NSTE-ACS to
assess the beneﬁt between invasive and conservative strategy for short- and long-term
survival. We searched PubMed for published studies from 1990 to November 2012
that studied the effects of an invasive vs. conservative strategy in patients with NSTE-
ACS, and using the search terms non-ST-elevation myocardial infarction, unstableJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Cangina, acute coronary syndromes, invasive strategy and conservative strategy. The
primary endpoints were all-cause mortality at 30 days and 1 year.
Results: Seven published studies were included in the present meta-analysis. The
pooled analyses shows that invasive strategy decrease the chance of death (risk ratio
[RR] [0.839] [95% conﬁdence interval [CI] {0.648-1.086}; I2, 86.46%]) compared to
conservative strategy during 30 days. Furthermore, invasive treatment could also
decrease the mortality (RR [0.276] [95% CI {0.259-0.294}; I2, 94.58%]) compared to
conservative strategy until 1 year.
Conclusions: In NSTE-ACS, compared with conservative strategy, the invasive
strategy has a comparable beneﬁt to decrease the mortality of short- and long-term.
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JAK2V617F mutant positive polycythemia Vera complicating acute coronary
syndrome: a report of 2 cases and literature review
Yang Ming, Zeng Yong
Peking Union Medical College Hospital
Objectives: To review the clinical features, diagnosis, prognosis and treatment of
polycythemia Vera (PV) complicating acute coronary syndrome (ACS).
Methods: The clinical data of two PV complicating ACS patients admitted to Peking
Union Medical College Hospital were retrospectively analyzed and the review of
recent literatures was performed.
Results: Case 1 was a 65-year old man who had been diagnosed PV with a positive
result of JAK2V617F mutation 3 years ago. At presentation, the patient was suffering
from recurrent angina pecteris, and coronary angiography revealed that there was a
severe (80%) lesion in the middle segment of left circumﬂex and a Xience V stent was
implanted. After the percutaneous transluminal coronary intervention (PCI), second-
ary prevention for coronary heart disease and hydroxyurea for PV were given and the
patient has been followed up regularly for more than three years and he is going on
well. Case 2 is a 44-year old man who was diagnosed PV with a positive result of
JAK2 mutation 3 years ago and hydroxyurea, interferon, aspirin was prescribed. He
was then to develop splenic infarction, thrombosis of splenic vein,regional portal
hypertension, severe varices of fundus of stomach and upper gastrointestinal
bleeding. 2 months ago, an AMI of inferior wall occurred and the angiographic
ﬁndings demonstrated an thrombotic lesion in the proximal segment of the right
coronary artery with a moderate stenosis (60%). 1 month ago,an AMI of anterior wall
developed and coronary angiography discovered that there were diffuse thrombus in
the proximal segment of left anterior descending artery with a severe stenosis (90%)
and a complete occlusion in the right coronary artery. After double antiplatelet
therapy with anticoagulation therapy of warfarin was given, the patient recovered
gradually.
Conclusions: PV complicating ACS is relatively rare. According to recent studies,
positive result of JAK2V617F mutation, leukocytosis, age greater than 65 years and
positive history of thrombosis were the most important predictors of cardiovas-
cular events. Clinicians should combine clinical features, Coronary angiography
ﬁndings and complications in hope of making an individualized treatment. For
those with thrombotic lesion in the coronary artery due to the hypercoagulative
state caused by PV, it should be cautious to carry out a coronary revascularization
treatment.
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Comparison of Circulating Dendritic Cells and Monocyte Subsets at Different
Stages of Atherosclerosis: insights from optical coherence tomography
Zhuang Jianhui, Zhu Guofu, Li Xiankai, Xu Yawei
Shanghai Tenth People’s Hospital, Tongji University School of Medicine
Objectives: Proinﬂammatory dendritic cells (DC) and monocytes are critically
involved in the proceeding and destabilization of atherosclerosis. Recent studies have
reported potential associations of speciﬁc patterns of circulating DCs and monocytes
with the incidence of coronary artery disease (CAD) and ST-elevation myocardial
infarction (STEMI); however, further information of DC and monocyte subsets on
plaque morphology and vulnerability is uncertain and required.
Methods: Forty-seven CAD patients with borderline lesions (stenosis 50%-70%) by
coronary angiography (CAG) were enrolled, while 31 subjects free of luminal
diameter narrowing  50% served as controls. Likewise, 35 patients with STEMI
were enrolled and conﬁrmed with the presence of thrombosis by CAG. Plaque features
of 47 CAD patients were evaluated at the site of the minimum lumen area and culprit
lesions by optical coherence tomography. Peripheral blood (6 ml) was collected from
each patient and drawn into heparin-anticoagulated tubes at entry. Circulating myeloid
DCs (mDCs), plasmacytoid DCs (pDCs) and monocyte subsets were analyzed using
ﬂow cytometry. Plasma levels of biomedical markers, including Lp-PLA2, PTX3,
FABP3, FABP4 and myeloperoxidase, were measured using commercial available
ELISA assays.
Results: There was no discrepancy in the peripheral total white blood cell count,
differential count among three groups. Compared to control group, patients with CAD
and STEMI had signiﬁcantly lower proportions of mDC1, mDC2, pDC and a
remarkable higher proportion of monocytes with intermediate CD16 expression
(Mon2, CD14+CD16+) in peripheral blood. In the OCT subgroup, patients with thin-
cap ﬁbroatheroma (TCFA) had a lower proportion of mDC2 than those without TCFA
(0.70%  0.38% and 1.42%  0.51%, P¼0.021). Otherwise, Mon2 proportion
retained a higher level in patients with TCFA relative to those without TCFA
(17.82%  3.69% and 14.19%  2.37%, P¼0.034). When proportions wereardiovascular Disease Clinical Research C125
converted into absolute value, as oppose to a gradual rise in the number of Mon2/ml,
the number of mDC2/ml remain gradually decreased with the progress of plaque
vulnerability. Plasma levels of Lp-PLA2, PTX3, FABP4 and myeloperoxidase, all of
which reﬂected coronary plaque vulnerability, were positively correlated with the
number of Mon2/ml, but negatively with the number of mDC2/ml.
Conclusions: Circulating subsets of mDC2 and Mon2 appear to be promosing
markers of plaque stabilization and rupture.
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Relationship between Stress Hyperglycemia and in hospital Mortality and
Complications in Patients with Acute Myocardial Infarction
Zhou Na, Li Zhen
First Afﬁliate Hospital Of Dalian University
Objectives: To investigate the effect of stress hyperglycemia on the mortality and
cardiovascular events in patients with acute myocardial infarction (AMI).
Methods: The study covered 1226 patients with the diagnosis of acute myocardial
Infarction admitted in CCU from January 2010 to December 2012 in the First
Afﬁliate Hospital of Dalian University. Based on the level of fasting blood glucose
(FBG), all patients were grouped into two groups: high blood glucose group (HBG
group, 7mmol/L) and non-high blood glucose group (non-HBG group, <7mmol/L).
Based on the history of diabetes were grouped into non-diabetes mellitus group
(NDM group) and diabetes mellitus group (DM group). According to the level of
FBG, patients within DM and NDM group were further divided into groupA
(FBG<7.0mmol/L), groupB (7.0mmol/LFBG<9.0mmol/L), groupC (9.0mmol/
LFBG<11.1mmol/L),groupD (FBG11.1mmol/L), respectively. Compare the dif-
ferences of the mortality and the rate of acute heart failure, cardiogenic shock and
main arrhythmias among these groups.
Results: The rate of high FBG is 34.1% in all AMI, among 37% patients without
history of diabetes mellitus. Compare with the 808 non-HBG groups patients, the 418
HBG group patients had higher mortality (9.1% vs 2.1%) and higher rate of acute
heart failure (37.8% vs 21.2%), cardiogenic shock (7.9% vs 0.7%) and main ar-
rhythmias (25.6% vs 16.5%) (all P<0.01). The mortality (6.4% vs 3.7%) and the rate
of acute heart failure (35.9% vs 23%) and cardiogenic shock (6.6% vs 1.7%) are
greater in the 362 DM group patients than the 864 NDM group (P<0.05).Among the
NDM group, the mortality and cardiovascular complications increased incrementally
with the increasing of FBG. Compared with groupA, the mortality and the rate of
acute heart failure, cardiogenic shock and main arrhythmias of groupB, groupC,
groupD are signiﬁcantly higher (all P<0.05). Compared with groupB, that mortality of
groupD increase obviously (30% vs 2.0%, P<0.01). In the DM group, the mortality
showed no signiﬁcant differences with the increased FBG levels, but the rate of acute
heart failure increased incrementally as FBG reached 9 mmol/L compared with group
A (P<0.01). The mortality of impaired fasting glucose (IFG) patients is similar to the
patients with normal FBG (2.4% vs 1.9%,P>0.05), and signiﬁcantly lower than the
patients with FBG7.0mmol/L (11.5% vs 2.4%,P<0.01).
Conclusions: The stress hyperglycemia could be used as a predictor of inhospital
mortality and cardiovascular events for patients with AMI. The elevation of FBG
increases the mortality and the incidence of acute heart failure, cardiogenic shock, and
main arrhythmias of patients with AMI. But the effects were not consistent between
DM and NDM patients. In NDM patients, as the FBG level increased, the mortality
increased signiﬁcantly, but this results was not obtained in DM group. In DM group,
the incidence of acute heart failure was signiﬁcantly increased as the FBG level
increased.
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The changes of PPARg and EPCs in patients with ACS complicated with
diabetes mellitus and the effect of Irbesartan on them
Li Xiaoyan, Sun Qing
Department of Cardiology, General Hospital of Jinan Military Region
Objectives: To observe the level of PPARg and EPCs in patients suffered from ACS
combined with Type-2 diabetes mellitus (T2DM) and ACS without T2DM, analysis
the relationship between PPARg, EPCs and ACS, T2DM, furthermore explore the
inﬂuence of Irbesartan on them to study the mechanisms of endothelial protection
beyond the antihypertensive effect of Irbesartan, hoping to ﬁnd a new treatment
method for ACS combined with T2DM.
Methods: 102 patients suffered from ACS was enrolled into our study, of which 52 of
them combined with T2DM (ACSDM group) and the other 50 patients only suffered
from ACS. Meanwhile, we selected 30 patients without coronary heat disease and
T2DM as the control group. To all patients, blood was drew when they were enrolled
to detect the level of PPARg and CD34+/CD309+ EPCs. All basic clinic data, CAG
and then Gensini score were compared among all groups. ACSDM group patients
were divided into A, B two group randomly. Patients, who were in A group, were
treated with Irbesartan 75mg po qd excepting conventional treatment of coronary heart
and diabetes. Patients, who wre in B group, were treated without Irbesartan. Blood
was drew again after 12 weeks. The level of PPARg was detected by enzyme-linked
immunosorbent method, meanwhile EPCs was detected by Flow cytometry instru-
ment. We analyed datas of each group by applicating of SPSS17.0.
Results: (1) The basic clinic data among each group, such as age, sex, body mass
index (BMI), smoking history, blood pressure, stain use, TG, HDL-CH, TC, LDL-CH,
blood urea nitrogen, creatinine were no difference (P all>0.05). CHD history, STEMI/
NSTEMI were no difference in ACS group and ACSDM group (P all>0.05). FPG,C126 JACC Vol 64/16/Suppl C j October 16–1HbA1c in the ACSDM group were signiﬁcantly much more than those in the ACS
group and control group (P <0.05). (2) The levels of PPARg of ACS group and
ACSDM group, when compared with control group (295.5625.06 ng/L), were
decreased signiﬁcantly (P all <0.05), and the ACSDM group was much lower than the
ACS group (P<0.05). (3) EPCs levels in ACS and ACSDM group were also
signiﬁcantly lower, when compared with control group (0.05840.0142%, and the
ACSDM group was much lower than the ACS group (P<0.05). 4 Gensini points in
ACSDM group was much higher than that of the ACS group (42.2425.46 VS.
30.2618.35, P<0.01). 5 Levels of PPARg and EPCs were signiﬁcatly correlated
positively (r¼0.658, P<0.01). Gensini scores of patients with ACS was correlated
negatively with both level of PPARg (r¼-0.484,P<0.05), and EPCs (r¼-
0.435,P<0.05). Levels of PPARg and EPCs in combined group were signiﬁcantly
correlated positively (r¼0.558, P<0.01). 6 After 12 weeks intervention of irbesartan,
the level of PPARg of A group increased signiﬁcantly compared with pre-treatment
levels [(226.1725.95) ng/L VS. (234.5526.20) ng/L, P<0.01], so did the level of
EPCs [(0.02840.0111) % VS. (0.03110.0102) %, P<0.01]. There was a signiﬁcant
positive relationship between them (r¼0.767, P<0.01). The level of PPARg and EPCs
of B group had on statistical difference after 12 weeks conventional treatment
(P all>0.05).
Conclusions: The level of PPARg, EPCs of patients with ACS are siganiﬁcantly
lower than those of control group, being much lower in ACSDM group. PPAR g and
EPCs level both decrease with the increasing of the degree of coronary artery stenosi.
Irbesartan, can improve the levels of PPARg and EPCs in patients with ACS and
T2DM, which probably become a new targets for therapeuty.
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Bleeding outcomes in low-mediate risk acute coronary syndrome patients
receiving stenting predicted by adenosine diphophate induced platelet
aggregation after initiation of clopidogrel: 6 months follow-up
Cui Tongtao, Huimin Yu, Taiming Dong, Bin Zhang, Hong Yan, Handong Wu,
Hongtao Liao, Lijun Jin
Department of Cardiology, Guangdong General Hospital, Guangdong Academy of
Medical Sciences, Guangdong Cardiovascular Institute
Objectives: The correlation of enhanced platelet responder to clopidogrel with
bleeding outcome and entry-site complication has rarely been characterized in China
population undergoing percutaneous coronary intervention (PCI). The aim of present
study is to access the prognostic signiﬁcance of optimal platelet inhibition according
to a given clinical state and ethnicity.
Methods: A total of 278 non high risk acute coronary syndrome (ACS) patients
indicated for PCI were enrolled.Adenosine diphophate induced maximal platelet
aggregation (ADP-PG max) was assessed with Lumi-Aggregometer by light trans-
mission aggregometry method. The primary endpoint was the incidence of Throm-
bolysis in Myocardial Infarction (TIMI) deﬁned bleeding outcome and signiﬁcant
entry-site complication within hospital and 6 months follow-up period. Blood was
obtained for platelet aggregation 24h after PCI and 1 month follow up respectively.
Receiver-operating characteristic (ROC) curve analysis was conducted to reveal the
optimal platelet aggregation value deﬁning enhanced clopidogrel responder for as-
sociation of measurements with endpoints.
Results: A total of 24 patients (8.6%) met with primary endpoint in the study, while 4
(1.4%) TIMI major bleeding events, 11 (4.0%) minor bleeding events and 9 (3.2%)
signiﬁcant entry-site complications were observed. Follow-up ADP-PG max
(OR¼0.96, 95%CI, 0.93-0.99; p¼0.008) and renal insufﬁciency (OR¼3.38 95%CI,
1.26-9.19; p¼0.02) were associate with the prediction of bleeding events. The optimal
cutoff for follow up ADP-PG max was 24.5% [area under the curve 0.72 (95%
conﬁdence interval 0.59-0.85), p<0.001]. Bleeding occurred in 26.2% of patients with
clopidogrel enhanced response (16/61), as compared with 3.7% of remaining patients
(8/217), (hazard radio, 9.26; p<0.001).
Conclusions: In conclusion, enhanced clopidogrel responsiveness was associated with
a higher risk of bleeding and entry-site complication. Platelet function test detected at
an appropriate sampling time after clopidogrel administration may help identify high
bleeding risk patients after coronary intervention.
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Discrepancy in Measuring On-Clopidogrel Platelet Responsiveness by
Vasodilator-Stimulated Phosphoprotein Phosphorylation and Platelet
Aggregation Is Associated with Smoking Status Following ST-Elevation
Myocardial Infarction
Zhou Xin, Jing Sun, Guo-Hong Yang, Wen-Jie Ji, Rui-Yi Lu, Xin-Lin Liu,
Zhao-Zeng Guo, Ji-Hong Zhao, Tie-Min Jiang, Yu-Ming Li
Tianjin Key Laboratory of Cardiovascular Remodeling and Target Organ Injury,
Institute of Cardiovascular Disease and Heart Center, Pingjin Hospital
Objectives: To investigate the potential mechanism accounting for the discrepancy of
VASP phosphorylation and platelet aggregation (PAG) in evaluating high on-clopi-
dogrel platelet reactivity in patients following ST segment-elevation myocardial
infarction (STEMI).
Methods: 90 consecutive STEMI patients scheduled for emergency percutaneous
coronary intervention (PCI) were enrolled. Platelet reactivity after clopidogrel loading
dose (300 mg) was determined by two methods [platelet reactivity index (PRI),
measured by vasodilator-stimulated phosphoprotein (VASP) phosphorylation ﬂow9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
